Search Results

Since the health care industry has been experiencing labor shortages, the agencies are trying to figure out a way to investigate the "serial mergers" in the initial notification process.

As lawmakers scrutinize the nation's pharmacy benefit managers, the California insurer expects to save $500 million in annual drug costs by replacing most of CVS Health's PBM services by January 2025.

Top-flight athletes work with personal coaches to unlock their best selves. Why isn't that true for agency owners?

Managing utilization growth of high-cost brand products with potential for off-label use helped minimize spend in some of the faster-growing drug categories like migraine and diabetes, says a new report.

Vice funds, which include "sin stocks" – concentrated in alcohol, tobacco, weapons and gambling, have the longest track record and remain a key approach for anti-environmental, -social and -governance investors.

Weeks before the CMS is releasing a list of drugs eligible for price negotiations, the Justice Department filed a motion, contesting the Chamber's move to block the program, claiming the pause would harm the public.

Some employers don't make enough productivity-related data and other metrics available to employees.

The FDA failed to consider the cumulative effect of removing several important safeguards at the same time, Circuit Judge Jennifer Walker Elrod said.